Skip to main content
. 2022 Oct 31;9:1052943. doi: 10.3389/fmed.2022.1052943

Figure 3.

Figure 3

Forest plot of the association between SII and PFS in mCRPC patients. SII, systemic immune-inflammation index; PFS, progression-free survival; mCRPC, metastatic castration-resistant prostate cancer.